Physician profile
Preston Harmon
NPI 1881076891
$16,864.38
in general payments reported to CMS, 2019-2025
36 companies · $2,342 in 2025
The $2,342 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,256 · 2020: $2,605 · 2021: $1,262 · 2022: $1,216 · 2023: $1,686 · 2024: $4,496 · 2025: $2,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,892 · Travel and Lodging: $613 · Entertainment: $19.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,891.66 |
| Travel and Lodging | $613.27 |
| Entertainment | $19.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,130.22 | 2019-2024 | Senza |
| Abbott Laboratories | $3,220.69 | 2019-2025 | Eterna, Proclaim, Octrode |
| Medtronic, INC. | $2,466.03 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Si-Bone, INC. | $1,029.74 | 2023-2025 | |
| Biotronik Nro, INC. | $984.33 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $861.76 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nalu Medical, INC. | $510.20 | 2024-2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $423.51 | 2021-2025 | Xtampza |
| Abbvie INC. | $384.03 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $324.16 | 2021-2025 | Relistor |
| Spinal Simplicity, LLC | $275.49 | 2020-2025 | Ha Minuteman G3-R |
| Stryker Corporation | $247.39 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $238.62 | 2021 | |
| Globus Medical, INC. | $224.47 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $191.97 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $179.88 | 2022 | |
| Stimwave Technologies Incorporated | $136.72 | 2020 | |
| Painteq LLC | $129.96 | 2023 | Painteq |
| Pfizer INC. | $115.82 | 2019-2024 | |
| Vertos Medical, INC. | $114.38 | 2022 | |
| Scilex Pharmaceuticals INC. | $113.96 | 2021-2025 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $82.96 | 2021-2022 | |
| Amgen INC. | $75.93 | 2019 | |
| Biotissue Holdings INC. | $70.54 | 2021 | |
| Saluda Medical Americas, INC. | $55.68 | 2025 | Evoke |
| Eisai INC. | $33.66 | 2020-2021 | |
| Bioventus LLC | $26.32 | 2023 | Durolane |
| Vertex Pharmaceuticals Incorporated | $20.71 | 2025 | |
| Merz North America, INC. | $15.22 | 2019 | |
| Horizon Therapeutics Plc | $14.48 | 2021 | |
| Pacira Therapeutics, INC. | $14.39 | 2019 | |
| Valinor Pharma, LLC | $13.92 | 2025 | Movantik |
| Spr Therapeutics, INC | $13.81 | 2025 | Sprint Pns System |
| Allergan, INC. | $12.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.